Deep search
Rewards
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
UK firm GSK to pay $2.2bn over Zantac cancer claims
UK pharmaceutical giant GSK says it will pay as much as $2.2bn (£1.68bn) to settle thousands of cases in US courts over claims that a discontinued version of its heartburn drug Zantac caused cancer. The firm announced that it has reached agreements with 10 law firms who represent around 80,
GSK share price surges after $2.2bn Zantac drug settlement
GSK has settled lawsuits in the US that alleged the drugmaker’s now-discontinued heartburn drug Zantac triggered cancer
GSK Shares Climb on $2.2 Billion Zantac Lawsuit Settlement
GSK topped the Stoxx Europe 600 index after the pharmaceutical company agreed to pay up to $2.2 billion to settle thousands of U.S. lawsuits over claims its discontinued heartburn medicine Zantac caused cancer.
GSK settles 4 Zantac lawsuits claiming heartburn drug caused cancer
GSK announced Wednesday that it has settled four cases in California that were linked to its now-discontinued heartburn drug Zantac. The company didn't disclose a settlement figure.
GSK shares jump on $2.2 billion Zantac settlement
By Maggie Fick and Yamini Kalia (Reuters) -GSK shares jumped as much as 6.5% on Thursday after the British drugmaker struck a $2.2 billion settlement over U.S. lawsuits that alleged its discontinued heartburn drug Zantac caused cancer.
GSK settles vast majority of Zantac claims for $2.2 billion
The British drugmaker reached a $2.2 billion settlement to resolve around 80,000 lawsuits over claims its Zantac heartburn remedy causes cancer
GSK Rises After Settling Zantac Cases for Up to $2.2 Billion
GSK Plc shares surged after the UK pharma company agreed to pay as much as $2.2 billion to resolve about 80,000 US court cases alleging that its old reflux medication Zantac was contaminated with a suspected carcinogen.
GSK surges 6.5% after $2.2 billion Zantac lawsuits settlement
Shares of GSK rose as much as 6.5% on Thursday after the British drugmaker agreed to pay up to $2.2 billion to settle lawsuits in the United States that claimed its discontinued heartburn drug Zantac caused cancer.
Food
3d
Why PepsiCo is backing the $2bn Kamala Harris-led effort to empower women in agriculture
The snacking giant – along with other global giants – has committed to a $2bn initiative aimed at advancing gender equality ...
Arabian Business
2h
Dubai woos digital startups as it looks to triple number of app developers, targets £27.2bn boost
Dubai Chamber of Digital Economy is supporting startups and fostering growth as it presents highlights at Expand North Star ...
10d
on MSN
Powerball winner wins lawsuit to hold onto $2bn prize after he was accused of stealing ticket
Powerball winner Edwin Castro will keep his record-breaking $2.04 billion prize after a California judge tossed a lawsuit ...
Beverage
13d
Breaking news: PepsiCo snaps up Siete Foods for $1.2bn
The acquisition of the Texas-based family-owned maker of Mexican-inspired snacks and foods marks a significant step for ...
Arabian Business
8h
Dubai real estate sector recorded $4.2bn of transactions last week, including $14.6m Palm Jumeirah apartment
The Dubai real estate sector recorded AED15.46bn ($4.2bn) of transactions last week, according to data from the Land ...
6d
on MSN
Ares bolsters real estate business with $5.2bn takeover
Ares Management has agreed to pay up to $5.2bn to buy the international arm of real estate investment manager GLP Capital ...
globalconstructionreview
4d
Denmark launches $4.2bn carbon capture and storage tenders
The Danish Energy Agency has launched tenders worth $4.2bn to build a carbon capture and storage network. The tenders cover ...
IPE
9h
Fondo Telemaco seeks asset managers for mandates worth €2.2bn
Telemaco’s assets under management amount to €2.46bn, as of the end of August this year, split into three sub-funds ...
Artemis
13d
Central Europe flooding industry loss between US $2.2bn and US$3.4bn: Verisk
Insurance industry losses from the recent severe flooding that struck central Europe in September are estimated to range ...
bolnews
4d
Pakistan, Saudi Arabia sign 27 MoUs valuing $2.2bn in multiple sectors
Pakistan and Saudi Arabia on Thursday signed 27 Memorandum of Understandings (MoUs) valuing US$2.2 billion in various sectors ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback